In this Issue
Past • Present • Future
Guest Chief Medical Editors’ Page
By Ronald M. Fairman, MD, and Edward Y. Woo, MD
Have the results shown a significant improvement in outcomes with a new generation of devices?
By Frederico Bastos Gonçalves, MD; Sander ten Raa, MD, PhD; Daniël Eefting, MD, PhD; Ellen V. Rouwet, MD, PhD; Johanna M. Hendriks, MD, PhD; and Hence J. M. Verhagen, MD, PhD
Important considerations to improve outcomes.
By Manish Mehta, MD, MPH, and Jeffrey C. Hnath, MD
How we diagnose and treat type I endoleaks by careful evaluation of patients, devices, and imaging modalities.
By Benjamin Colvard, MD, and Jason T. Lee, MD
Although a common complication, type II endoleaks are not always benign and require innovative treatment strategies.
By Naveed U. Saqib, MD; Kristofer M. Charlton-Ouw, MD; and Ali Azizzadeh, MD, FACS
A comprehensive strategy composed of the essential experience and technology needed to achieve satisfactory outcomes when treating short-necked aneurysms.
By Amir H. Malkawi, MD, FRCS; Matt M. Thompson, MD, FRCS; and Ian M. Loftus, MD, FRCS
Declining reimbursement may affect this procedure and the medical device industry.
By Sean P. Lyden, MD
Ask The Experts
By Michael J. Singh, MD, FACS, RPVI; Sharif Ellozy, MD; Mark K. Eskandari, MD, FACS; Ross Milner, MD; Ronald M. Fairman, MD; and Peter R. Nelson, MD, MS
By Thomas S. Maldonado, MD, FACS; Luis A. Sanchez, MD, FACS; Edward Y. Woo, MD; and Mark Farber, MD
Vessel Update: SFA
Koen Deloose, MD, discusses the potential advantages of this technology, results to date, and remaining questions to be answered.
The recipient of the Gore & Associates 2012 Dedication to Analysis of Clinical Outcomes Award shares his perspective on the current assessment, treatment protocols, and clinical research for patients with carotid artery disease.